Half-year report · HY
3939.TEDINET S100Y3HG
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥765m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥670m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥670m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥7.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥6.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.0bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.6bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥821m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥551m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥236m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥744m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥539m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥516m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥651m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥486m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.12 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.42 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.93 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 71.5% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥44m |
| Healthy Lifespan Extension Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥714m |
| Healthy Lifespan Extension Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥714m |
| Healthy Lifespan Extension Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥111m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥2.1bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥2.1bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥3m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥950m |
| Solutions Development Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥412m |
| Solutions Development Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥338m |
| Solutions Development Businessreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥74m |
| Solutions Development Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥16m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥74m |
| Healthy Lifespan Extension Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥551m |
| Healthy Lifespan Extension Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥551m |
| Healthy Lifespan Extension Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥57m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥737m |
| Solutions Development Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥344m |
| Solutions Development Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥330m |
| Solutions Development Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥14m |
| Solutions Development Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥839m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of intangible assets inv cf | Prior1InterimDuration | -103757000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -138526000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1InterimDuration | -27845000 | JPY |
| Payments for lease and guarantee deposits inv cf | InterimDuration | -19078000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1InterimDuration | 15611000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | InterimDuration | 51000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1InterimDuration | -355141000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | 13000 | JPY |
| Other net inv cf | InterimDuration | 13000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -538822000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -235593000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -142434000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -137214000 | JPY |
| Redemption of bonds fin cf | Prior1InterimDuration | -30000000 | JPY |
| Redemption of bonds fin cf | InterimDuration | -15000000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -5288000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -7472000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -308472000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -355929000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -486194000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -515616000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -9165000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 22684000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -482685000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 92318000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 3430050000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 3327111000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 2947365000 | JPY |
| Cash and cash equivalents | InterimInstant | 3419429000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 221625000 | JPY |
| Salaries and allowances sga | InterimDuration | 270430000 | JPY |
| Directors compensations sga | Prior1InterimDuration | 126016000 | JPY |
| Directors compensations sga | InterimDuration | 110949000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 37367000 | JPY |
| Provision for bonuses sga | InterimDuration | 40482000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | -144000 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | 2185000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E32603-000MedicalAndNursingCareCloudPlatformBusinessReportableSegmentsMember | 1780683000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E32603-000HealthyLifespanExtensionBusinessReportableSegmentsMember | 550555000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E32603-000SolutionsDevelopmentBusinessReportableSegmentsMember | 329949000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2661188000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 2661188000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E32603-000MedicalAndNursingCareCloudPlatformBusinessReportableSegmentsMember | 4698000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E32603-000HealthyLifespanExtensionBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E32603-000SolutionsDevelopmentBusinessReportableSegmentsMember | 13737000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 18435000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -18435000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |